Will payors adopt this therapy? I'm having trouble figuring out why payors would adopt coverage for this therapy. Negative ICER. Fatalities from peanut range 150 to 250 per year (statistically insignficant vs gen pop and all fatal cause comparisons). Why should they cover this for anxious mothers? EpiPen cost for any AE's is cheaper than any proposed cost of this therapy.
Payor uptake?
- Thread starter anonymous
- Start date
-
- Tags
- None
Yes you have a good point and that said wonder if it will even be profitable? This place looks like a cluster F so glad I am moving on.
Prior authorization criteria. 3 documented ER visits in last 24 months, otherwise cash only. Medicine is actuarial...run by insurance companies.
Not all plans the same my man! Sure their will be a PA for most all coverage but also sure Insurance will approve for the appropriate patients.
Why do most morons speak so definitively?
Why do most morons speak so definitively?
Keep telling yourself that, sport! You'll overcome it. You are a stellar salesman. You are the best. No one can beat you in sales. You will win every award. You are living in a dream world, yet you call anyone other than yourself a moron. Sorry bud, this is a dog.
Quit yer bitchin you two.
OP makes a solid point. Too many unknowns at this point. Startups are always risky.
OP makes a solid point. Too many unknowns at this point. Startups are always risky.
This is not a viable business. And for that reason, I’m out.
Payors and most allergists want an FDA approved peanut allergy (insert other food allergy products) desensitization product. Five dollar peanut flour will fu€k around and seriously injure someone one day and the allergist using it will learn a hard lesson. If five dollar peanut flour desensitization was easy and safe, EVERYONE would be doing it. EVERYONE who’s targeted by Aimmune isn’t going to use Palforzia, but everyone who does use it will know it’s safe and effective and YES it will cause reactions in patients. However patients, doctors and payors will all be using the product under the terms and guidance within the label approved by the FDA and FPS a product that is produced under GMP. Payors are going to catch hell if they try to impose a 3 ER visit minimum! Parents, pediatricians and allergists are going push back on that type of stringent requirement. If you’re in the ER once for a peanut allergy, you have already been scared enough! Who waits and tries to see if their child can survive 2 life threatening more scares?!?!?! WTF? Lastly, why is everyone over reacting about patients having to carry an EpiPen? They already to carry the damn pen and NEED TOO!!!!!! All of the speculation, illogical thoughts, and negative assumptions are mind boggling. Palforzia is far from a cure, but it’s a good therapy and food allergies have increasing incident rates, unfortunately NOT decreasing incident rates. To anyone screaming DBVT is the answer needs to go kick rocks, their application is for an even smaller set of patients 4-11 year olds and most food allergy deaths actually occur in teens - kids who have more autonomy and tend to get careless about protecting themselves from their food allergies. Couple that with DBVT not hitting their primary efficacy endpoint. How does that product solve any problems? If it gets approved, it has potential to serve a subset of patients, but misses a lot of patients.
"Payors are going to catch hell"
Hahaha that's a funny one. Are you new to this game? They've been "catching hell" for years now and it hasnt been stopping them. Obviously, you have a lot riding on this. I get it....its your day job - you're livelihood. I dont wish ill on you at all, but for those who are gainfully employed, considering this opportunity should only be for those who are currently unemployed. 3 ER visits is an exaggeration as PA criteria, but the point is clear - this wont be a cakewalk and the income stream may not be enough to keep this company afloat.
Hahaha that's a funny one. Are you new to this game? They've been "catching hell" for years now and it hasnt been stopping them. Obviously, you have a lot riding on this. I get it....its your day job - you're livelihood. I dont wish ill on you at all, but for those who are gainfully employed, considering this opportunity should only be for those who are currently unemployed. 3 ER visits is an exaggeration as PA criteria, but the point is clear - this wont be a cakewalk and the income stream may not be enough to keep this company afloat.
I’m very tenured professional, not sure about original poster, but some comments are initiating a productive dialogue.Nothing to gain from this experience, but I thought the commentary about 3 ER visits was ridiculous as well.Payers are in place to control costs. However, there are numerous factors payers take into consideration and this is “novel” in that it’s an FDA approved product with GMP and reduces risk. In a litigious society that is important perspective for everyone at the table. No one is expecting a cakewalk. The are too few balanced conversations evaluating pros/cons not just “talking heads” or investors speculating on stock or shorting stock.I forgot it’s rare to have robust dialogue in this forum ✌How do both REMS and a black box warning fit into this equation?
Tenured Professional?? LMAO ! What does that mean...you stack the meds on the shelves ???
This startup scheme is going to be a bust. I am a long time senior DM (31 years with many Presidents Club awards) and looked into this as a sideline. After some investigation etc am totally amused by how idiotic the business strategy is. Only wet behind the ears newbies would take to this.
If you were long tenured (love that term) you would see thru this in a second LOL. !!
“For those considering this opportunity...” The entire sales force has been given offers. So anyone “considering” working at Aimmune is too late. Try to keep up skippy.